TerminatedNo phase
The Occurrence of Atrial Fibrillation After Totally Endoscopic Cardiac Surgery
Key facts
- Who runs it
- Jessa Hospital
- Where
- Belgium1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Terminated
- People taking part
- 152 people enrolled
- Started
- 22 Mar 2023
- Ended
- 9 Nov 2024
- Type of study
- Interventional
- Treatments tested
- FibriCheck
- Record updated
- 29 November 2024
- Why it stopped
- After the passing of the principal investigator, the clinical trial could not be continued.
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- >18 years old
- Patients undergoing elective endoscopic cardiac surgery (totally endoscopic coronary artery bypass grafting or endoscopic valve replacement)
Who cannot take part
- Concomitant or redo surgeries
- Preoperative atrial fibrillation
- Patients that do not understand Dutch or French or English
- Patients that do not have a smartphone
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim of this study is to investigate the occurrence of new-onset postoperative atrial fibrillation after totally endoscopic cardiac surgery.
The group in the trial
- Totally endoscopic cardiac surgeryTreatment being tested
Patients will be monitored using the FibriCheck application to detect atrial fibrillation until 30 days postoperative.
Treatment: FibriCheck
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 29 November 2024